Bioluminescent imaging of Cdk2 inhibition in vivo

Keyphrases

• Cyclin-dependent Kinase 2 (CDK2) 100%
• Bioluminescence Imaging 100%
• S-phase Kinase-associated Protein 2 (Skp2) 75%
• Ubiquitin Ligase 75%
• Luciferase 75%
• Cell Cycle-dependent 50%
• Binding Site 25%
• Small Interfering RNA (siRNA) 25%
• Phosphorylation 25%
• Threonine 25%
• Fusion Protein 25%
• Drug Target 25%
• R-roscovitine 25%
• Human Tumor Cells 25%
• Inhibitory Proteins 25%
• Protein-peptide Complexes 25%
• F-box Protein 25%
• Flavopiridol 25%
• Inhibitory Drugs 25%
• Cyclin-dependent Kinase Inhibitor p27 25%
• Bioluminescent Reporter 25%

Biochemistry, Genetics and Molecular Biology

• Luciferase 100%
• Ubiquitin Ligase 100%
• Bioluminescence 100%
• Cell Cycle 66%
• Binding Site 33%
• Small Interfering RNA 33%
• F-Box Protein 33%
• CDKN1B 33%
• Threonine 33%
• Chimeric Protein 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Ubiquitin Protein Ligase 100%
• Luciferase 100%
• Neoplasm 33%
• Binding Site 33%
• Small Interfering RNA 33%
• Threonine 33%
• Roscovitine 33%
• Flavopiridol 33%
• F Box Protein 33%
• S Phase Kinase Associated Protein 2 33%
• Cyclin Dependent Kinase Inhibitor 1B 33%
• Chimeric Protein 33%